EXHIBIT 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with Amendment No. 1 to the Annual Report of Emerald Bioscience, Inc. a Nevada corporation (the “Company”) on Form 10-K for the year ending December 31, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Doug Cesario, Chief Financial Officer of the Company, hereby certify, that, to my knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
A signed original of this written statement required by Section 906 has been provided to Emerald Bioscience, Inc., and will be retained by Emerald Bioscience, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
/s/ Doug Cesario |
|
Doug Cesario Chief Financial Officer (Principal Financial Officer) May 29, 2019 |